Company Filing History:
1 out of 27 
1 out of 7 
1 out of 260 
Years Active: 2012-2013
Title: MahnHoon Park: Innovator in Biotechnological Advancements
Introduction
MahnHoon Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions for therapeutic applications. With a total of 2 patents, his work focuses on enhancing the efficacy of medical treatments.
Latest Patents
MahnHoon Park's latest patents include a method for preparing an antigen effective for preventing anthrax infection. This innovative method utilizes successive column chromatography processes to purify anthrax protective antigens, achieving improved purity while effectively removing impurities. This approach allows for the economical large-scale production of the anthrax protective antigen. Another significant patent is for a liposome designed for liver-specific delivery and release of therapeutic nucleic acids or drugs. This composite, which includes an apolipoprotein A-1 and a liposome-forming material, is capable of specifically delivering therapeutic agents to the liver and selectively releasing them into hepatic cells, thereby enhancing the therapeutic effects of these agents.
Career Highlights
Throughout his career, MahnHoon Park has worked with esteemed organizations such as the Mogam Biotechnology Research Institute and the Korea Center for Disease Control and Prevention. His experience in these institutions has allowed him to contribute to important research and development projects in the field of biotechnology.
Collaborations
MahnHoon Park has collaborated with notable colleagues, including Meehyein Kim and Soo In Kim. These partnerships have further enriched his research endeavors and have led to advancements in his field.
Conclusion
MahnHoon Park's innovative work in biotechnology, particularly in the development of methods for antigen purification and targeted drug delivery, showcases his commitment to improving medical treatments. His contributions are significant in the ongoing efforts to enhance therapeutic efficacy and patient outcomes.